• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Rune Labs Scores $12M to Power Personalized Parkinson’s Care with AI

by Fred Pennic 01/11/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

– Rune Labs, a precision neurology company, announced a strategic $12M funding round, bringing its total to over $42 million. The round was led by Nexus NeuroTech Ventures, a new brain disorder fund, with participation from existing investors.

– This strategic partnership marks a significant step forward in Rune Labs’ mission to revolutionize Parkinson’s disease care through personalized data and cutting-edge technology.

Transforming Parkinson’s Care with Data and AI

Rune Labs’ innovative approach revolves around StrivePD, a comprehensive software ecosystem featuring:

– FDA-cleared Apple Watch integration: Tracks tremors and dyskinesia, providing patients with continuous insights into their symptoms.

– Personalized data dashboards: Offer patients and clinicians valuable data visualizations for informed decision-making.

– Actionable insights powered by AI: Rune Labs is at the forefront of using generative AI to deliver personalized recommendations for managing PD.

Building on Success and Embracing AI

Rune Labs’ achievements extend beyond StrivePD. The company’s StriveStudy platform facilitates clinical trials for promising new therapies, while partnerships with leading innovators like BlueRock Therapeutics and Aspen Neuroscience further strengthen its commitment to personalized care. Additionally, Rune Labs is actively exploring generative AI tools to deliver even more personalized insights to patients at scale.

“For too long, we’ve been waiting for a cure that never comes,” says Benjamin Stecher, Chair of Rune Labs’ Patient Advisory Board and a person living with Parkinson’s. “StrivePD has empowered me to understand my disease better and work with my doctor to manage it more effectively. I believe Rune Labs is on the right track to transform how we receive care and ultimately find a cure for Parkinson’s.”

A Brighter Future for Patients with PD

With its data-driven approach, cutting-edge partnerships, and unwavering commitment to patient empowerment, Rune Labs is on a mission to redefine PD care. This latest funding boost fuels their journey to develop AI-powered solutions that unlock personalized treatment plans, optimize clinical trials, and ultimately, bring hope to the millions living with this debilitating disease.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |